SLC5A2 and heart failure: For example, metformin may cause lactic acidosis in patients with renal impairment or heart failure [51], TZDs may increase the risk of heart failure or ischemic events in patients with cardiovascular disease [53], and SGLT-2 inhibitors may cause volume depletion or ketoacidosis in patients with dehydration or insulin deficiency [54-56].